Sothema
CCSEMA:SOT315.00
MAD
+6.00
(+1.94%)
ISIN
MA0000012833
Return %
Stock
S&P 500
1Y
-12.21
14.20
3Y
56.87
81.12
5Y
5.28
68.34
Capital Structure
FRC
•
in mil. unless spec.Working Capital
FRC
•
in mil. unless spec.Growth Rates
FRC
•
in mil. unless spec.Semi-annual Revenue
FRC
•
in mil. unless spec.Semi-annual Earnings Per Share
FRC
•
in mil. unless spec.Semi-annual Dividends Per Share
FRC
•
in mil. unless spec.Company Description
- CEO
- Lamia Tazi
- Full Time Employees
- 1,355
- Sector
- Health technology
- Industry
- Pharmaceuticals: major
- Address
- Bouskoura Morocco
- Website
- sothema.com
- Similar Companies
- Business
- Société de Thérapeutique Marocaine S.A. (Sothema) is a Morocco-based pharmaceutical and biotechnology company engaged in the research, development, manufacturing, licensing, marketing, and distribution of generic and branded prescription pharmaceuticals, biosimilars, and over-the-counter healthcare products. The company operates through specialized pharmaceutical production segments, offering a diverse array of dosage forms and therapeutic formulations, including sterile injectable products such as ampoules, lyophilized vials, pre-filled syringes, ophthalmic solutions, and large-volume intravenous infusions; oral solid formulations comprising film-coated tablets, hard gelatin capsules, extended-release caplets, effervescent forms, and powders for oral suspension; oral liquid formulations including pediatric syrups, oral solutions, and drops; and topical formulations encompassing medicated creams, ointments, gels, and suppositories. Its commercial portfolio covers major therapeutic categories, including oncology and hematology; cardiology and vascular diseases; endocrinology and metabolic disorders, including recombinant human insulins; central nervous system and neurological disorders; anti-infectives and broad-spectrum antibiotics; gastroenterology; rheumatology, analgesics, and anti-inflammatory therapies; respiratory diseases; and dermatology. Sothema also provides third-party contract development and manufacturing organization (CDMO) services, tech-transfer execution, regulatory filing support, quality control analytics, and cold-chain distribution solutions for international pharmaceutical corporations. In recent corporate and operational developments, Sothema has significantly scaled its biotechnology and biosimilar manufacturing infrastructure at its primary industrial site in Bouskoura; advanced technology-transfer alliances with global biopharmaceutical partners for the localized fill-and-finish production of biosimilars, vaccines, and specialized oncology treatments; expanded into the medical cannabis industry following regulatory approval to manufacture cannabis-based active pharmaceutical ingredients and therapeutic formulations; and broadened its commercial footprint across West Africa and the Middle East, reinforced by manufacturing operations through its regional subsidiary, West Afric Pharma in Senegal. Founded in 1976, Sothema is headquartered in Bouskoura, Casablanca, Morocco.